- Report
- March 2025
- 139 Pages
Global
From €2658EUR$2,999USD£2,289GBP
- Report
- June 2025
- 150 Pages
Global
From €2392EUR$2,699USD£2,060GBP
- Report
- April 2024
- 80 Pages
Poland
From €1329EUR$1,500USD£1,145GBP
- Report
- April 2024
- 80 Pages
Russia
From €1329EUR$1,500USD£1,145GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1329EUR$1,500USD£1,145GBP
- Report
- April 2024
- 100 Pages
Africa
From €1772EUR$2,000USD£1,526GBP
Provigil is a prescription medication used to treat excessive sleepiness caused by certain medical conditions, such as narcolepsy, obstructive sleep apnea, and shift work sleep disorder. It is a central nervous system (CNS) stimulant drug, classified as a Schedule IV controlled substance by the U.S. Drug Enforcement Administration. Provigil is approved by the U.S. Food and Drug Administration (FDA) for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder.
Provigil is part of the larger CNS drug market, which includes drugs used to treat a variety of neurological and psychiatric conditions. These drugs are used to treat conditions such as depression, anxiety, insomnia, and attention deficit hyperactivity disorder (ADHD).
Some of the companies in the Provigil market include Cephalon, Inc., Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more